Piracetam Film-Coated Tablets (400 mg / 800 mg / 1200 mg)
Healthy Inc is a specialized global supplier and exporter of advanced neurology, neuro-rehabilitation, and cognitive-enhancement therapeutics. We provide ultra-high-purity, kinetically stabilized Piracetam Film-Coated Tablets (400 mg / 800 mg / 1200 mg), manufactured in WHO–GMP certified, high-compression oral solid dosage facilities. This “First-Generation Nootropic & Neuromodulator” is a massive-volume, highly lucrative export to neurology centers, geriatric care networks, stroke-rehabilitation clinics, and government health ministries in the CIS, LATAM, Africa, and Southeast Asia, serving as the globally trusted intervention for cortical myoclonus, vertigo, and the aggressive rehabilitation of ischemic cerebrovascular damage.
Product Overview
This highly advanced formulation contains Piracetam, a cyclic derivative of GABA that fundamentally acts as a “metabolic supercharger” for the brain. It protects neurons from oxygen starvation and dramatically improves communication between the brain’s hemispheres without acting as a traditional stimulant or sedative.
The “Cognitive Enhancer & Microcirculation” Specialist:
- Mechanism 1 (Neuronal Membrane Fluidity): As the brain ages or suffers trauma, the lipid membranes of neurons become stiff and rigid, preventing neurotransmitters from binding properly. Piracetam actively integrates into these cell membranes, physically restoring their fluidity and flexibility. This aggressively upregulates neuroplasticity, allowing the brain to form new memory pathways and recover lost motor functions after a stroke.
- Mechanism 2 (The Hypoxia Shield & Erythrocyte Deformability): Piracetam is a life-saver in ischemic environments. It prevents red blood cells (erythrocytes) from becoming stiff and sticking to the walls of blood vessels. By making the blood cells highly flexible, it massively improves microcirculation in the brain’s deepest capillaries without causing vasodilation or altering systemic blood pressure. It also allows brain cells to survive much longer during periods of low oxygen (hypoxia).
- Mechanism 3 (Cortical Myoclonus Control): Beyond cognitive enhancement, massive doses of Piracetam are globally mandated by neurologists to suppress Cortical Myoclonus (sudden, uncontrollable, violent muscle jerks), acting as a highly tolerable, non-sedating alternative to heavy anti-epileptic drugs.
Product Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-gauge PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic API.
| Active Ingredient | Strength | Primary Clinical Function |
|---|---|---|
| Piracetam Ph.Eur./USP | 400 mg | Initiation / Pediatric Standard: Base unit for pediatric dyslexia and mild vertigo management. |
| Piracetam Ph.Eur./USP | 800 mg | Global Cognitive Standard: Standard adult maintenance dose for age-related cognitive decline and memory impairment. |
| Piracetam Ph.Eur./USP | 1200 mg | Acute Neurology Standard: Massive-dose unit designed specifically for Cortical Myoclonus and intensive post-stroke rehabilitation protocols to minimize pill burden. |
| Excipients | Microcrystalline Cellulose / Croscarmellose Sodium / Macrogol (PEG) / Colloidal Silicon Dioxide / Magnesium Stearate | High-Density Diluent / Superdisintegrant / Premium Film-Coating (Engineered specifically to compress the massive API load into a smooth, swallowable, moisture-resistant oblong tablet) |
*Pack Sizes: 10×10 Blisters (Optimized specifically for strict, high-volume chronic neurology dispensing where patients may consume 2.4g to 4.8g daily).
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers, Neurology Distributors, and Hospital Procurement Boards.
| HS Code | 3004.90.99 (Medicaments containing other active substances – Neurology/Nootropics) |
| CAS Number | 7491-74-9 |
| Dosage Form | Film-Coated Tablet (Immediate Release) |
| Packaging | High-Density PVC/PVDC or Alu-Alu Blisters (STRICTLY MANDATORY). Piracetam is highly hygroscopic. If exposed to ambient humidity, the tablet will absorb water, swell, and degrade. Strict barrier packaging guarantees structural integrity across Zone IVb tropical climates. |
| Storage | Store strictly below 25°C in a dry place. Protect heavily from Moisture. |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
- High-Load Compressibility Engineering: Manufacturing a 1200 mg dose is a supreme pharmaceutical challenge. Most generic tablets of this size suffer from “capping” (where the top of the tablet shears off during compression) or become too brittle to survive shipping. Our facilities utilize advanced high-shear wet granulation and elite rotary press pre-compression technology. This physically forces the massive volume of Piracetam powder into a dense, rock-solid, yet rapidly dissolving core, which is then sealed with a slick Macrogol film-coating to ensure easy swallowing for elderly stroke patients.
Therapeutic Indications (Human Use)
Indicated for the targeted, non-sedating management of severe cognitive and cerebrovascular dysfunction:
- Cognitive Disorders: Symptomatic treatment of psycho-organic syndrome features, including memory loss, attention disorders, and lack of drive in the elderly.
- Cortical Myoclonus: Treatment of myoclonus of cortical origin, irrespective of aetiology, often used in combination with other anti-myoclonic therapies.
- Vertigo: Treatment of vertigo and associated balance disorders (excluding dizziness of vasomotor or psychic origin).
- Sickle Cell Anemia (Regional Protocol): Prophylaxis and treatment of vaso-occlusive crises in sickle cell disease (due to its profound effect on erythrocyte deformability).
Dosage & Administration
Recommended Dosage (Strictly as per Neurologist Guidelines):
- Cognitive Decline / Vertigo: Typically 2.4 g to 4.8 g daily, divided into two or three doses (e.g., one 800 mg tablet three times a day).
- Cortical Myoclonus: Treatment must be highly individualized, often starting at 7.2 g daily and increasing up to a massive 24 g daily, divided into 2 or 3 doses.
- Administration (THE 4 PM RULE – CRITICAL): Because Piracetam drastically increases brain energy metabolism, it can cause severe insomnia if taken late in the day. The final dose of the day MUST be taken before 4:00 PM. Tablets must be swallowed whole with water.
Safety Warnings (CRITICAL Regulatory & Clinical Data):
- Severe Renal Impairment (Absolute Contraindication): Piracetam is almost exclusively excreted by the kidneys completely unchanged. In patients with severe renal failure (Creatinine Clearance < 20 mL/min), the drug will rapidly accumulate to toxic levels in the blood. It is strictly contraindicated in this population.
- Hemorrhage & Bleeding Risk: Due to its effect on platelet aggregation and reducing blood viscosity, Piracetam must be used with extreme caution in patients with severe hemorrhage (e.g., active gastrointestinal bleeding or hemorrhagic stroke) or those undergoing major surgery.
- Hyperkinesia & Nervousness: The most common side effects are weight gain, severe nervousness, hyperkinesia (abnormal involuntary movements), and agitation, particularly in elderly patients taking high doses.
Global Export & Contract Manufacturing Services
Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and NGO Health Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Neurological and Nootropic Formulations. Whether you are looking for a reliable Government Tender Supplier for stroke-rehabilitation clinics in the CIS or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely, secure delivery of WHO-GMP certified products.